Lighting the Way to a Cure

  • Financials
  • Patient Library
  • Blog
  • Calendar
en English
en Englishes Spanishfr Frenchde Germanit Italiannl Dutchru Russianzh-CN Chinese (Simplified)ja Japanesehi Hindiiw Hebrewpt Portuguese
FSHD Header Logo
mobile-logo
  • Who We Are
        • About Us
          • History
          • Mission
          • Our Team
        • Our Impact
          • Therapeutic Accelerator
          • Education
          • Advocacy
          • Our Partners
        • Extraordinary Measures
          • 2021 Donor Impact Report
          • 2020 Donor Impact Report
  • Understanding FSHD
        • What is FSHD
          • Symptoms
          • Diagnosis
          • Early-onset FSHD
          • Genetic Testing
        • Living with FSHD
          • Newly Diagnosed?
          • Finding Care
          • Symptom Management
          • Patient Library
        • FSHD University
          • Physical Health
          • Wellness
          • Research
  • Get Involved
        • Support Us
          • Ways to Give
          • Become a Torch Bearer
          • Raise Awareness
          • Volunteer
          • Fundraise
        • Advance Research
          • Patient Involvement
          • Join the True Cost of FSHD Study
          • Clinical Trials
          • Donate tissue
        • Connect
          • Find Your Local Chapter
          • Join the Community
          • World FSHD Alliance
          • Online Communities
        • Events
          • Walk & Roll to Cure FSHD
          • Events Calendar
          • FSHD 360 Regional Conferences
          • FSHD Connect Conference
  • Research
        • For Patients & Families
          • Advance Research
          • True Cost of FSHD Study
          • TestFSHD genetic testing
          • Clinical Trials
        • For Researchers
          • Apply for a Grant
          • Grants We Have Funded
          • Resources
          • Int’l Research Congress
        • For Clinicians
          • FSHD Masterclass
          • ICD-10
        • For Industry
          • Therapeutic Accelerator
          • Clinical Trial Research Network
          • Drug Development Pipeline
          • Voice of the Patient Report
  • News
    • Media Library
    • Blog
      • Living with FSHD
        • Health and Medicine
        • PT and Exercise
        • Tips and Tricks
        • Mental Health
      • FSHD Society News
      • FSHD Research
      • Fundraising & Events
      • Media & PR
    • FSHD Society Radio
    • The FSHD Advocate
  • JOIN US
  • DONATE

What a difference 30 years have made

Home / FSHD Society News / What a difference 30 years have made

Posted on: Mar 01, 2021

Time flies when you have your nose to the grindstone, working with focus and determination on a lofty goal. It has been an amazing 30 years since Daniel Perez and Steve Jacobsen started the Society. Back then, almost no one was doing research on facioscapulohumeral muscular dystrophy (FSHD). The human genome had not yet been mapped. The internet was in its infancy. People diagnosed with FSHD went through life never meeting another soul with the same condition. Doctors told their patients to avoid exercise or, worse, to expect to not live beyond their 20s. Today, thanks to the work started by our pioneers, supported first by a handful and now by thousands of families, we are a worldwide community of more than 10,000 patients, families, friends and supporters, researchers and clinicians. We have identified the genetic mechanism causing FSHD and nearly a dozen companies are working on treatments.

Check out our 30th anniversary timeline, marking major milestones in our progress. While three decades is far too long a time for patients who need treatments now, this is a timely reminder that we have in fact come a great distance. A dream that once upon a time seemed unimaginable, is now almost within reach, with all of us pushing forward together.

Click on the image to expand.

FSHD Society Timeline 1991-2020

 

Share

Filed Under: FSHD Research, FSHD Society News

Comments

  1. Alberto L. Rosa says

    March 1, 2021 at 9:15 am

    Dear frieds,
    In year 2007 we published our seminal work (Kowaljow et al., 2007) proposing that DUX4 is the causative pathogenic protein in FSHD. The original manuscript, submitted to Nature Medicine in 2003, was rejected (no review). In the same year (2003), Sara Winokur allowed me to present ALL our results at the FSHD IRC in LA (2003). Our studies were entirely performed in my laboratory in Cordoba (Argentina). Our results showed, for the firs time, that DUX4 was a toxic protein. At that time, most of the community was looking in another directions to explain the pathogenesis in FSHD. In addition, no lab had been able to find any connection between DUX4 and FSHD. In year 2003, considering the difficulties to publish our results, I proposed to A. Belayew to collaborate to publish together those findings showing that DUX4 is toxic and could underlie the pathogenesis of FSHD. Our paper, however, took 4 more years (four!) to ble published (Kowljow et al., 2007)… In any case, our pioneer contribution triggered most of the following research in the field of DUX4 and, together with the Science paper in 2010, conducted to the tremendous advances in the current FSHD therapies. I strongly suggest that our contribution (2007′ Dr Rosa’s lab paper) must be included in your timeline.
    Thanks so much and best regards,
    Alberto L. Rosa (alrosa@ucc.edu.ar)

    Reply
    • jkinoshita says

      March 2, 2021 at 3:04 pm

      Thanks for alerting us to this oversight. We’ve now updated the diagram.

      Reply
      • Anonymous says

        March 19, 2021 at 11:40 am

        Sir when will fshd be cured

        Reply
    • Scott Harper says

      March 3, 2021 at 8:58 am

      Thank you to Alberto and Alexandra and all their colleagues for putting DUX4 on the map. This bold and dogged pursuit indeed deserves recognition. Thanks June for amending the timeline.

      Scott Harper, Columbus, Ohio

      Reply
  2. Syamkumar R says

    September 19, 2021 at 7:45 am

    It’s really happy to see the progress and appreciate the efforts. Is there any study going on in India as a part of this?

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

SEARCH

Categories

  • FSHD Research
  • FSHD Society News
    • Extraordinary Measures
  • Fundraising & Events
  • General
  • Living with FSHD
    • Health and Medicine
    • Mental Health
    • PT and Exercise
    • Tips and Tricks
  • Media & PR

Sign up for Email Alerts

Stay up to date with the latest FSHD news and updates from FSHD Society.

CONNECT WITH US

Proud Member World FSHD Alliance (1)
Footer-Logo-min

Donation Address:

Department 960, P O Box 4106
Woburn, MA 01888    U.S.A.

General Mailing Address:

75 North Main Street, Suite 1073
Randolph, MA 02368 U.S.A.

(781) 301-6060

  • DONATE
  • Donate
  • Join Us
  • Inclusivity & Equity
  • Privacy Policy
  • Contact Us
  • Glossary Of Scientific Terms
Digital Marketing by